Displaying 49 - 60 of 85
General Hepatology

Who is at risk? How do we approach these interconnected challenges in the clinics?

Webcasts
View
General Hepatology

Summary and close

Webcasts
View
Metabolism, Alcohol & Toxicity

Setting the scene: from NASH to MASH and beyond

Webcasts
View
Metabolism, Alcohol & Toxicity

Boehringer Ingelheim: MASH in focus: novel insights on diagnosis, management and coordinated patient care (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

The MASH epidemic: insights on pathophysiology and systemic interconnections

Webcasts
View
Metabolism, Alcohol & Toxicity

State-of-the-art: screening and diagnostic tools in MASH

Webcasts
View
Metabolism, Alcohol & Toxicity

Breaking new ground: evidence-based care pathways and advances in clinical development

Webcasts
View
Metabolism, Alcohol & Toxicity

Navigating MASH in 2024 and beyond: audience Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Understanding New Goals of Therapy in PBC

Webcasts
View
Immune-Mediated and Cholestatic Diseases

CymaBay Therapeutics: “Targeting New Approaches in PBC” (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Welcome and Introduction

Webcasts
View
Displaying 49 - 60 of 85